A Useful Support System for Psychiatric Diagnostics and Follow-up in Adult Psychiatry and Primary Care (ASPP)
Launched by KAROLINSKA INSTITUTET · Apr 21, 2023
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
The ASPP trial is studying a new way to help doctors diagnose and monitor mental health conditions in adults. Researchers want to create a set of simple self-assessment tools—like questionnaires—that ask about common symptoms of mental disorders. These tools aim to gather important information about a person's mental health and help doctors make better decisions about treatment. By using a method called Item Response Theory, the team will evaluate these questions to ensure they are effective and easy to use, potentially narrowing them down to about 10 key items.
If you're an adult experiencing psychiatric problems, you might be eligible to participate in this study. There are no specific exclusions, which means almost anyone with mental health issues can join. As a participant, you can expect to complete these self-assessment questionnaires and contribute to research aimed at improving mental health care for everyone. This trial is currently recruiting, so there's an opportunity to help shape future mental health diagnostics!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with psychiatric problems
- Exclusion Criteria:
- • None
About Karolinska Institutet
Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stockholm, , Sweden
Stockholm, , Sweden
Stockholm, , Sweden
Stockholm, , Sweden
Stockholm, , Sweden
Patients applied
Trial Officials
Mats O Adler, MD
Principal Investigator
Karolinska Institutet, Department of Clinical Neuroscience
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported